Abstract. Second-hand smoke is associated with increased risk of cardiovascular diseases. So far, little is known about the signaling mechanisms of second-hand smoke-induced vascular dysfunction. Endothelial junctions are fundamental structures important for maintaining endothelial barrier function. Our study showed that sidestream cigarette smoke (SCS), a major component of second-hand smoke, was able to disrupt endothelial junctions and increase endothelial permeability. Sidestream cigarette smoke stimulated the phosphorylation of p38 mitogen-activated protein kinase (MAPK) and myosin light chain (MLC). A selective inhibitor of p38 MAPK (SB203580) prevented SCS-induced loss of endothelial barrier integrity as evidenced by transendothelial resistance measurements. Resveratrol, an antioxidant that was able to inhibit SCS-induced p38 MAPK and MLC phosphorylation, also protected endothelial cells from the damage. Thus, p38 MAPK mediates SCS-induced endothelial permeability. Inhibition of p38 MAPK may have therapeutic potential for second-hand smoke-induced vascular injury.
Introduction
Second-hand smoke is associated with heart disease deaths in adult nonsmokers in the United States (1, 2) . Nonsmokers exposed to second-hand smoke are more likely to develop cardiovascular diseases compared with nonsmokers not exposed to smoke (3) , but at present little is known about the mechanisms by which secondhand smoke contributes to vascular dysfunction.
The endothelium of the vascular system forms a barrier between the blood and extravascular compartments to regulate the trans-endothelial flux of liquid, plasma proteins, and white blood cells. Endothelial cells establish the selective barrier function through cell-cell junctions (4) . Tight junctions and adherens junctions are two basic structures important for maintaining endothelial barrier integrity. Here, we propose that sidestream cigarette smoke (SCS), a major component of second-hand smoke, disrupts endothelial barrier by activating signals controlling cell contraction and cellcell junctions.
Actin and myosin interaction plays a critical role in the development of contractile force in endothelial cells (5) , and their interaction is regulated by the phosphorylation status of myosin light chain (MLC) (6, 7) . Endothelial junctions are mechanically coupled to the actin cytoskeleton (4, 5) . Thus, the generation of mechanical forces through MLC phosphorylation may lead to disruption of the cell-cell junctions, which then results in an efflux of macromolecules from the bloodstream and tissue edema. Vascular injuries caused by inflammatory mediators are often coupled with vessel wall leakage and edema formation (8 -10) . Recent studies suggest that pro-inflammatory stimuli such as thrombin, VEGF, and TGF-β1 increase endothelial permeability by boosting MLC phosphorylation (11 -13) .
MLC phosphorylation is regulated by MLC kinase (MLCK) and Rho kinase (14) . While MLCK directly phosphorylates MLC, Rho kinase regulates MLC phosphorylation indirectly through inactivation of MLC phosphatase (15, 16) . p38 mitogen-activated protein kinase (MAPK) is another important mediator of vascular permeability (10, 17) . p38 MAPK activation has been shown to increase endothelial permeability through both MLC-dependent and independent pathways (18, 19) . In the present study, we examined the signaling pathways regulating SCS-induced endothelial permeability. The extract from sidestream cigarette smoke was prepared and used in the experiments. Our studies indicate that p38 MAPK and MLC mediate SCS-induced endothelial barrier dysfunction.
Materials and Methods

Antibodies and reagents
Rabbit anti-MLC, anti-phospho-MLC, rabbit anti-p38 MAPK, and anti-phospho-p38 MAPK antibodies were purchased from Cell Signaling (Beverly, MA, USA). Goat anti-VE-cadherin antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Resveratrol, Rho-kinase inhibitor Y27632, p38 MAPK inhibitor SB203580, and an inactive control SB202474 were purchased from Calbiochem (San Diego, CA, USA).
Cell culture
Human pulmonary artery endothelial cells (HPAEs) were obtained from Cambrex (East Rutherford, NJ, USA) at passage 3, cultured in complete EGM-2 media (Cambrex) supplemented with 10% fetal bovine serum, and used at passages 5 -8. The endothelial cell cultures were maintained at 37°C in a humidified atmosphere of 5% CO 2 -95% air in T-75 tissue culture flasks, plates, or dishes coated with 0.2% gelatin and grown to confluent monolayers. Cells were seeded into 6-well plates for immunoblotting analysis or into eight-well gold microelectrode chambers (Applied Biophysics, Troy, NY, USA) for measurement of transendothelial electrical resistance (TER).
Preparation of SCS solutions
SCS extract was prepared by combusting research filtered 2R4F cigarettes (University of Kentucky Tobacco Research and Development Center, Lexington, KY, USA) in a 4-liter side-arm flask. The SCS was bubbled into phosphate-buffered saline (PBS) using an automatic peristaltic pump at a rate of 200 ml / min. SCS extract was filtered through a 0.1-µm filter unit (Millipore, Bedford, MA, USA) and used the same day. SCS concentration was determined spectrophotometrically (230 nm). For all experiments, an absorbance of 1 at 230 nm was considered 100%. Final concentrations of these solutions are expressed as percent values. Final concentrations from 5% -20% were used in the studies. To study signal transduction pathways affected by SCS, the Rho-kinase inhibitor Y27632 (5 µM), p38 MAPK inhibitor SB203580 (2.5 µM), and an inactive control SB202474 (2.5 µM) were used. HPAEs were pretreated with the inhibitors for 15 min and then exposed to SCS.
Immunoblotting
After treatments, cells were washed with PBS (Invitrogen, Carlsbad, CA, USA) and lysed with cell lysis buffer containing PBS, 1% Triton X-100, and protease inhibitors (Sigma-Aldrich, St. Louis, MO, USA). Total cell lysates were cleared by centrifugation and boiled in SDS sample buffer for 5 min. Protein extracts were separated by SDS-PAGE on 10% or 12% gels for detection of p38 and MLC. The separated proteins were transferred to polyvinylidene difluoride (PVDF) membranes. The blots were subsequently blocked with 5% blocking buffer (1 × PBS, 5% milk, 0.1% Tween-20) at room temperature for 1 h and then incubated with primary specific antibodies at room temperature for 1 h or overnight at 4°C. After 6 washes for 5 min each with PBST (1 × PBS, 0.1% Tween-20), the membrane was incubated with horseradish peroxidase-conjugated IgG secondary antibody at room temperature for 1 h, followed by six washes for 5 min each with PBST. Immunoreactive proteins were detected using an enhanced chemiluminescent detection system according to the manufacturer's protocol (Pierce, Rockford, IL, USA). Densitometry analysis was carried out using the Quantity One program (Biorad, Hercules, CA, USA).
Immunofluorescence
Endothelial cells grown on gelatin-coated coverslips were washed 3 times in ice-cold PBS and fixed in prechilled (−20°C) methanol after treatment with SCS. They were then blocked in 3% BSA in PBS for 1 h at room temperature and incubated with antibody to VECadherin. After incubation, the cells were washed with PBS and incubated with Alexa-594-labeled secondary antibodies (Molecular Probes, Eugene, OR, USA) for 1 h at room temperature. After three washes in PBS, the coverslips were mounted on slides using Prolong antifade mounting medium (Molecular Probes) and examined under an epifluorescence microscope Nikon U2000 with a 40× oil objective lens (Nikon, Tokyo).
Measurement of endothelial permeability
TER, an indicator of endothelial cell barrier integrity, was measured in real time using an electric cell-substrate impedance sensing (ECIS) system (Applied BioPhysics, Troy, NY, USA) as described previously (20) . For resistance experiments, HPAE cells were plated on sterile eight-well gold-plated electrode arrays (8W10E) pre-coated with 0.2% gelatin at 1 × 10 5 / well one day prior to the experiment. Fresh complete medium was added to the cells prior to the experiment. The arrays were then mounted on the ECIS system within an incubator (37°C, 5% CO 2 ) and connected to its recorder device. Monolayer resistance was measured at continuous intervals and normalized at time 0.
Statistics All values are expressed as means ± S.E.M. Data were analyzed by one-way analysis of variance (ANOVA) followed by the Bonferroni test. A P value <0.05 was considered significant.
Results
Disruption of endothelial barrier function and dynamics of adherens junctions following SCS challenge
We first examined the effect of side stream cigarette smoke on endothelial barrier function. Human pulmonary artery endothelial cells cultured on electrode culturewares were treated with different concentrations of SCS. SCS treatment decreased TER within minutes (Fig. 1A) . TER was able to return to basal level gradually within 2 -3 h. The immunostaining pattern of anti-VE-cadherin along the cell-cell contacts exhibited the presence of intact adherens junctions in confluent HPAE cells (Fig. 1B, Con) . SCS treatment induced disassembly of adherens junctions within minutes, as seen by the disrupted perimeter VE-cadherin staining (Fig. 1B, 15 and 30 min) . By 3 h after continuous SCS challenge, the cell perimeter staining of VE-cadherin was restored (Fig. 1B, 3 h) , which was consistent with TER recovery shown in Fig. 1A .
SCS challenge induces MLC and p38 MAPK phosphorylation
HPAEs were incubated either with an increasing dose (0, 5%, 10%, and 20%) of SCS for 15 min or one dose (20%) in time course experiments (0, 5, 15, 30, and 60 min). SCS challenge induced MLC ( Fig. 2A ) and p38 MAPK (Fig. 2B ) phosphorylation in a timeand dose-dependent manner.
Blockade of SCS-induced endothelial permeability by Rho-kinase and p38 MAPK inhibitors
To address the roles of Rho kinase and p38 MAPK signaling in SCS-induced endothelial permeability, we examined the effects of Rho-kinase and p38 MAPK inhibitors on SCS-induced MLC phosphorylation. Both Rho kinase and p38 MAPK inhibitors decreased SCSinduced MLC phosphorylation (Fig. 3A) . We then examined the effects of the selective Rho kinase and p38 MAPK inhibitors on preserving endothelial barrier function during the challenge with SCS extract. HPAEs cultured on electrode culturewares were pre-treated with either Rho kinase or p38 MAPK inhibitors and then challenged with 10% SCS. Both inhibitors significantly reduced the decrease of transendothelial resistance by SCS challenge (Fig. 3B) .
Resveratrol inhibits SCS-induced MLC and p38 MAPK phosphorylation and prevents SCS-induced endothelial permeability
Resveratrol is an antioxidant that has been shown to have protective effects against cardiovascular damage (21) . Here, we tested its effects on SCS-induced cell signaling and endothelial permeability. Resveratrol was used as an antioxidant in this particular study because it alone had no effect on transendothelial resistance but consistently inhibited SCS-induced decrease of transendothelial resistance. Pre-treatment of the cells with resveratrol for 30 min inhibited the phosphorylation of both p38 MAPK and MLC (Fig. 4A) and reduced the decrease of transendothelial resistance by SCS challenge (Fig. 4B) .
Discussion
There is increasing evidence suggesting that cigarette smoke not only affects those who smoke, non-smokers who are exposed to second-hand smoke environment are also adversely affected by the toxic substances of cigarette smoke (1 -3). Second-hand cigarette smoke has two components: sidestream smoke released from the burning end of a cigarette and mainstream smoke inhaled and then exhaled by an active smoker. Sidestream smoke accounts for about 85% of the total amount of second-hand smoke (2, 22) . Importantly, when compared with mainstream smoke, sidestream smoke contains more concentrated toxic chemicals (23) . Although it has been reported by others that cigarette smoke can induce endothelial dysfunction (24, 25) , the molecular mechanisms of the second-hand smoke induced-vascular injury are not well understood. In this study, we determined the effects of sidestream cigarette smoke extract on endothelial permeability and used this in vitro model to explore the underlying mechanisms and potential treatments.
We first tested the effects of sidestream cigarette smoke on endothelial junctional integrity. We observed the decrease in transendothelial electrical resistance and disruption of cell-cell junctions when HPAEs were exposed to SCS. The change of endothelial permeability is transient and reversible, and therefore permanent damage to the cells may not occur. Similar changes were also observed when HPAEs were treated with mainstream cigarette smoke extract (J Fu et al., unpublished data), suggesting that SCS could be as harmful as mainstream cigarette smoke. We then examined the signaling pathways involved in regulating sidestream cigarette smoke-induced endothelial permeability. After exposing human pulmonary artery endothelial cells to sidestream cigarette smoke extract, we observed the activation of cell signaling pathways (e.g., MLC phosphorylation and p38 MAPK activation) that have been shown to promote vascular injury (5, 10) . Even though SCS induced persistent P38 MAPK phosphorylation, MLC phosphorylation was transient, which could be due to dephosphorylation of MLC by MLC phosphatase. Inhibition of Rho kinase, which is known to stimulate MLC phosphorylation indirectly through inactivation of MLC phosphatase (15, 16) , blocked MLC phosphorylation induced by SCS treatment. Importantly, inhibition of p38 MAPK protected endothelial cells from SCSinduced damage by inhibiting the phosphorylation of MLC, suggesting that p38 MAPK activation is necessary for MLC phosphorylation. Thus, we provide new evidence supporting the link between second-hand smoke and vascular injury and disclose the signaling mechanisms that may lead to endothelial dysfunction and acute lung injury by second hand smoke exposure.
Cigarette smoke, which contains thousands of active compounds, for example, nicotine, carbon monoxide, and aromatic amines such as the carcinogenic compound o-toluidine (23), has been shown to decrease nitric oxide production, increase oxidative stress, and stimulate cytokine production (25 -29) . Thus, the chemicals in sidestream smoke extract may induce endothelial permeability through diverse signaling pathways. Exposure to second-hand smoke induces free radical generation (25, 29) , which could be a major cause of second-hand smoke-induced vascular injury. The oxidants can come directly from cigarette smoke and indirectly through activation of endogenous sources of free radicals, for example, NADPH oxidase (25, 29) . Studies from Yamaguchi et al. indicate that aqueous extract of cigarette smoke may contain stable oxidants with peroxynitrite-like activity (30 -32) . Interestingly, peroxynitrite-like species in cigarette smoke extract have been reported to oxidize plasma low-density lipoprotein (LDL) (31) . Oxidized LDL is known to play important roles in the early development of atherosclerosis (33) . Association of oxidized LDL with endothelial dysfunction is well established (34, 35) . Thus, oxidative modification of LDL could be an early cause of vascular endothelial dysfunction induced by secondhand smoke exposure and may facilitate the further development of cardiovascular diseases. Oxidant stress-mediated acute endothelial dysfunction has also been well studied (36) . Reactive oxygen species are able to activate phospholipases and their downstream signaling or alter the structure and function of cytoskeleton and adhesion molecules through oxidative modification (36, 37) . All those pathways may mediate second-hand smoke-induced endothelial permeability. Our studies pointed out the involvement of p38 MAPK. Resveratrol, a compound with antioxidant activity, was able to reduce SCS-induced endothelial permeability, which was correlated with its inhibitory effects on SCS-induced p38 MAPK and MLC phosphorylation.
Our studies allowed a better understanding of secondhand smoke-induced endothelial dysfunction, which may help us to design a strategy to prevent vascular injury from the damaging effects of second-hand cigarette smoke. Indeed, inhibition of p38 MAPK is showing promise as a therapeutic approach. SB203580, a selective p38 MAPK inhibitor, is now applied in the treatment of pulmonary diseases without significant side effects (38) . Thus, inhibition of p38 MAPK may provide protective effects against second-hand smoke-induced vascular injury in clinical settings. 
